Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
15.6M
-
Shares change
-
+2.93M
-
Total reported value, excl. options
-
$120M
-
Value change
-
+$17.3M
-
Number of buys
-
34
-
Number of sells
-
-32
-
Price
-
$7.65
Significant Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q1 2020
79 filings reported holding KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q1 2020.
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.6M shares
of 50M outstanding shares and own 31.25% of the company stock.
Largest 10 shareholders include FMR LLC (1.79M shares), SV Health Investors, LLC (1.72M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.68M shares), Vivo Capital, LLC (1.48M shares), Ikarian Capital, LLC (947K shares), BlackRock Inc. (872K shares), PICTET ASSET MANAGEMENT LTD (631K shares), Polar Capital LLP (588K shares), VANGUARD GROUP INC (560K shares), and ORBIMED ADVISORS LLC (421K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.